Chromogranin A as a Predictor of Progression, Regression or Stable Disease in Ileo-Cecal Neuroendocrine Tumors

被引：0
|
作者：
Jensen, K. [1 ,2 ]
Hilsted, L. [2 ]
Jensen, C. [2 ]
Mynster, T. [2 ]
Knigge, U. [2 ]
机构：
[1] Slagelse Hosp, Dept Surg, Copenhagen, Denmark
[2] Rigshosp, Neuroendocrine Tumor Ctr Excellence, DK-2100 Copenhagen, Denmark
来源：
NEUROENDOCRINOLOGY | 2011年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [41] Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease
    Thiis-Evensen, Espen
    Poole, Amalie Christine
    Hong-Thien Thi Nguyen
    Sponheim, Jon
    BMC CANCER, 2020, 20 (01)
  • [42] Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Labora, Amanda
    Shimizu, Takayuki
    Moore, Alexandra
    Premji, Alykhan
    Armstrong, Wesley R.
    Chen, Kevin Y.
    Link, Jason
    Chan, Charlotte S.
    Allen-Auerbach, Martin S.
    Donahue, Timothy R.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 6875 - 6882
  • [43] Granulocyte-Macrophage Colony Stimulating Factor Auto-Antibodies Are Produced by Lamina Propria Mononuclear Cells Isolated From Ileal Strictures of Pediatric Patients With Crohn Disease Undergoing Ileo-Cecal Resection
    Jurickova, Ingrid
    Chalk, Claudia
    Trapnell, Bruce C.
    Denson, Lee
    GASTROENTEROLOGY, 2011, 140 (05) : S2 - S2
  • [44] Somatostatin analogues to control disease progression in neuroendocrine tumors (NET):: A review of patients' characteristics and clinical outcome
    Costa, L
    Quintela, A
    Rodrigues, T
    Pinto, A
    Távora, I
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 32 - 32
  • [45] The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases
    Han, Xu
    Zhang, Chunyan
    Tang, Min
    Xu, Xuefeng
    Liu, Lingxiao
    Ji, Yuan
    Pan, Baishen
    Lou, Wenhui
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (05) : 527 - 535
  • [46] Progression of pancreatic neuroendocrine tumors (PanNETs) to metastatic disease is associated with MCT4 expression and metabolic heterogeneity
    Sadowski, M.
    Brautigam, K.
    Straub, J.
    Andreasi, V
    Kirchner, P.
    Maire, R.
    Dettmer, M.
    Schrader, J.
    Partelli, S.
    Falconi, M.
    Marinoni, I
    Perren, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 149 - 149
  • [47] ASO Visual Abstract: Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Labora, Amanda
    Shimizu, Takayuki
    Moore, Alexandra
    Premji, Alykhan
    Armstrong, Wesley R.
    Chen, Kevin Y.
    Link, Jason
    Chan, Charlotte S.
    Allen-Aurbach, Martin S.
    Donahue, Timothy R.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 1197 - 1198
  • [48] Netazepide, a Gastrin/CCK-2 Receptor Antagonist, Causes Regression of Type 1 Gastric Neuroendocrine Tumors and Reduces Expression of Chromogranin a and Histidine Decarboxylase Genes in Chronic Atrophic Gastritis
    Moore, Andrew R.
    Boyce, Malcolm J.
    Steele, Islay
    Campbell, Fiona
    Varro, Andrea
    Pritchard, D. M.
    GASTROENTEROLOGY, 2013, 144 (05) : S360 - S360
  • [49] Factors at time of diagnosis associated with progressive or stable disease in patients with Small Intestinal Neuroendocrine Tumors (SI-NETs)
    Schalin-Jantti, C.
    Kjellman, M.
    Knigge, U.
    Gronbaek, H.
    Thiis-Evensen, E.
    Welin, S.
    Sorbye, H.
    Schneider, M.
    Belusa, R.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 117 - 117
  • [50] Interest of serum and urinary 5HIAA, serotonin, chromogranin A and NT-proBNP assays as predictive factors for the development of carcinoid heart disease in neuroendocrine tumors
    Lecoeur, A.
    Sfeir, R. M.
    Damour, J.
    Lombard-Bohas, C.
    Gerard, L.
    Francois, L.
    Forestier, J.
    Walter, T.
    Chardon, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 162 - 162
12345